Biosergen AB Holds Extraordinary General Meeting
Biosergen AB held its extraordinary general meeting in Stockholm on August 6, 2026. Resolutions were adopted concerning amendments to the articles of association and a reduction of the share capital.
Biosergen AB conducted an extraordinary general meeting in Stockholm on August 6, 2026. The meeting resulted in the adoption of resolutions, including changes to the company's articles of association and a reduction of its share capital.
All proposals presented to the meeting were approved by the attendees. Further details regarding these resolutions are available on the company's website.
The specific implications of the amended articles of association and the capital reduction are expected to be detailed in subsequent communications from Biosergen AB.